FDA Inspection 1110458 — American CryoStem Corporation
The FDA completed an inspection of American CryoStem Corporation on October 8, 2019 in Monmouth Junction, NJ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 8, 2019
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Monmouth Junction, NJ (United States)